Form 4: Zimmer Biomet CEO Ivan Tornos Reports Stock Transactions

Ivan Tornos, President & CEO of Zimmer Biomet Holdings, Inc., reports the vesting of restricted stock units and subsequent stock sales to cover tax obligations.

Summary

• On March 6, 2024, Ivan Tornos, President & CEO of Zimmer Biomet Holdings, Inc., reported transactions involving the company's common stock.
• Specifically, 10,270 restricted stock units (RSUs) vested, each representing a contingent right to receive one share of Zimmer Biomet common stock.
• One-third of the RSUs vested on March 6, 2024, with the remainder vesting in two equal installments on March 6, 2025, and March 6, 2026.
• Following the vesting, Tornos disposed of 10,270 shares and 5,642 shares were withheld by the company to cover tax obligations at a price of $125.82.
• After these transactions, Tornos directly owns 26,753 shares of Zimmer Biomet common stock and 20,536 restricted stock units.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing reflecting standard executive compensation practices. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Future Outlook

The remaining RSUs will vest in two equal installments on March 6, 2025, and March 6, 2026.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Comparison to Industry Standards

• Monitoring insider transactions is a standard practice in corporate governance across the industry.
• Companies like Stryker (SYK) and Johnson & Johnson (JNJ), which are Zimmer Biomet's competitors, also have similar reporting requirements for their executives' stock transactions.
• The vesting schedules and tax withholding practices are generally consistent with industry norms for executive compensation.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders.
• The filing provides transparency to shareholders regarding executive compensation and stock ownership.

Key Dates